[Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests]. .
New oral anticoagulants promise to overcome essential drawbacks of traditional substances .
They have a predictable therapeutic effect , a wide therapeutic window , only limited interaction with food and drugs and can be administered p.o. .
with a fixed dose .
On the other hand , knowledge on the laboratory management of new anticoagulants is limited .
In the present article we discuss possible indications and available assays for monitoring of Rivaroxaban , Apixaban and Dabigatran .
Furthermore , we discuss interpretation of routine coagulation tests during therapy with these new drugs .
